Alimentiv CRO

about us


We are a niche GI contract research organization. We have been providing a complete range of clinical research services to a broad base of academic and industry clients since 1986.


We are global. We are a culturally diverse organization with a presence in two continents. Today, we have offices in London, Ontario, Canada, Amsterdam and San Diego.

We are collaborators. We work with pharmaceutical and biotechnology companies, government agencies, key opinion leaders and the investigator community to advance the development of effective treatments. From concept to completion, we provide tailored and innovative recommendations for the design and implementation of research.

We are pioneers. We are consistently developing new ways to improve clinical trial outcomes and accelerate drug development timelines. We were first to bring solutions for central imaging of endoscopy and histopathology to the market, and we recently built a translational science network that can accelerate and enhance early drug development.

We are recognized experts in inflammatory bowel disease (IBD) and clinical trial design. We are known as leaders in outcomes development, cluster randomization trials and centralized imaging solutions. Our experience in R&D and clinical research forms the basis for our integrated solutions to complex operational needs and regulatory standards.

cro-min

Therapeutic Areas and Services

more information »

Our People

Our leaders promote business integrity, collaboration and corporate responsibility. Their collective medical, operational and business expertise translates into quality solutions, timely execution and fiscal attentiveness to every project.

Dot

Executive

Jeff Smith

Chief Executive Officer

Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.

Background

Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).

Achievements

Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.

Ethos

“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”


Lisa Harrison

Chief Operations Officer

Lisa Harrison

Chief Operations Officer

Lisa was named a VP at Alimentiv in 2013 and subsequently named COO three years later. She succeeds by leading and partnering with other leaders to grow the business quickly in a stable way, while ensuring the company never loses sight of its purpose, people or focus.

Background

Lisa is an organizational strategist and senior operational leader who has been focused on the professional services, health care and technology sectors for over 30 years. She has led and consulted with fast-growing and high-change organizations around the world.

Achievements

Lisa’s operational knowledge, visionary perspectives and ability to connect people and ideas across many industries have helped her achieve great things with inspiring organizations and leaders. She has been part of successful start-ups, turnarounds, acquisitions or spinoffs, corporate redesigns and executive-level negotiations. She also supports or has been a board member for many charities.

Ethos

“Everyone needs to be grounded by a purpose. Mine is to build strong organizations that build strong people and communities.”


Hershell William Thompson

VP, Clinical Research

Hershell William Thompson

VP, Clinical Research

Hershell has led the Clinical Research division since 2019. He is responsible for end-to-end clinical trial services and the continuous development of resources and capabilities.

Background

Hershell has over 25 years of experience in medicine development. Prior to this role, Hershell was Senior Managing Consultant at Navitas Life Sciences and held senior roles at GSK and ICON Clinical Research where he was the Director of Clinical Process and Change Management. He also has a strong CRO services delivery background resulting from years as a clinical trials project lead and CRA.

Achievements

Over the past 20 years, Hershell has defined strategy and provided leadership for major R&D process improvement and organization redesign initiatives to resolve current issues and enable future success. He drove implementation of a change management framework throughout the clinical research organization, implementing standard methodologies and tools for managing change and leading complex change initiatives to the expected benefit.

Ethos

“Be authentic, breathe, listen. The time is now. There is no other opportunity than this moment to give your very best.”



Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.

Background

Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).

Achievements

Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.

Ethos

“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”



Lisa Harrison

Chief Operations Officer

Lisa was named a VP at Alimentiv in 2013 and subsequently named COO three years later. She succeeds by leading and partnering with other leaders to grow the business quickly in a stable way, while ensuring the company never loses sight of its purpose, people or focus.

Background

Lisa is an organizational strategist and senior operational leader who has been focused on the professional services, health care and technology sectors for over 30 years. She has led and consulted with fast-growing and high-change organizations around the world.

Achievements

Lisa’s operational knowledge, visionary perspectives and ability to connect people and ideas across many industries have helped her achieve great things with inspiring organizations and leaders. She has been part of successful start-ups, turnarounds, acquisitions or spinoffs, corporate redesigns and executive-level negotiations. She also supports or has been a board member for many charities.

Ethos

“Everyone needs to be grounded by a purpose. Mine is to build strong organizations that build strong people and communities.”



Hershell William Thompson

VP, Clinical Research

Hershell has led the Clinical Research division since 2019. He is responsible for end-to-end clinical trial services and the continuous development of resources and capabilities.

Background

Hershell has over 25 years of experience in medicine development. Prior to this role, Hershell was Senior Managing Consultant at Navitas Life Sciences and held senior roles at GSK and ICON Clinical Research where he was the Director of Clinical Process and Change Management. He also has a strong CRO services delivery background resulting from years as a clinical trials project lead and CRA.

Achievements

Over the past 20 years, Hershell has defined strategy and provided leadership for major R&D process improvement and organization redesign initiatives to resolve current issues and enable future success. He drove implementation of a change management framework throughout the clinical research organization, implementing standard methodologies and tools for managing change and leading complex change initiatives to the expected benefit.

Ethos

“Be authentic, breathe, listen. The time is now. There is no other opportunity than this moment to give your very best.”


Vipul Jairath

Vice President for Medical Research and Development

Vipul Jairath

Vice President for Medical Research and Development

Vipul oversees the global Medical R&D initiatives and services. In conjunction with the executive team and senior medical advisors, he assumes overall responsibility for research strategy, as well as performance of the organization’s Medical R&D services including medical operations, medical imaging, precision medicine, medical writing, medical monitoring, medical/biostatics advisory collaborations and IBD fellowships. He also provides medical oversight for the design of clinical trials, protocol development and imaging R&D endpoints. Vipul was previously Director of Academic Research and Development (2016-19).

Background

Dr Jairath obtained his BSc (Pharmacology) and Medical Degree from the University of Leeds (UK), DPhil (PhD) in Clinical Medicine from the University of Oxford and post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine. He is Professor of Medicine at the Schulich School of Medicine and Dentistry, and holder of the John and Susan McDonald Endowed Chair in Inflammatory Bowel Disease (IBD) at Western University.

His specialist clinical training in Gastroenterology was completed in London and Oxford, and he holds specialist certification in both Ontario and the UK. Prior to moving to Western in 2016, he was a National Institute for Health Research Clinical Trials Fellow at the Oxford Clinical Trials Research Unit and Consultant Gastroenterologist at Oxford University hospitals.

He is a practising gastroenterologist and specialist in inflammatory bowel disease, and his research interests in clinical therapeutics for IBD include design of clinical trials, development and validation of outcome measures for use in clinical trials, patient reported outcome measures and prediction modelling for response to therapy.

Achievements

Vipul has driven the development and validation of several novel indices for use in IBD clinical trials, like the UC-100 and the novel patient reported outcome measures, SIQ-UC and SIQ-CD. In addition, he was instrumental to the delivery of the REACT2 trial and to the design of the VERDICT trial, both of which are important clinical practice questions for patients with Crohn’s Disease and Ulcerative Colitis, respectively.

Ethos

“We are what we repeatedly do. Excellence, then, is not an act, but a habit.” — Aristotle



Vipul Jairath

Vice President for Medical Research and Development

Vipul oversees the global Medical R&D initiatives and services. In conjunction with the executive team and senior medical advisors, he assumes overall responsibility for research strategy, as well as performance of the organization’s Medical R&D services including medical operations, medical imaging, precision medicine, medical writing, medical monitoring, medical/biostatics advisory collaborations and IBD fellowships. He also provides medical oversight for the design of clinical trials, protocol development and imaging R&D endpoints. Vipul was previously Director of Academic Research and Development (2016-19).

Background

Dr Jairath obtained his BSc (Pharmacology) and Medical Degree from the University of Leeds (UK), DPhil (PhD) in Clinical Medicine from the University of Oxford and post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine. He is Professor of Medicine at the Schulich School of Medicine and Dentistry, and holder of the John and Susan McDonald Endowed Chair in Inflammatory Bowel Disease (IBD) at Western University.

His specialist clinical training in Gastroenterology was completed in London and Oxford, and he holds specialist certification in both Ontario and the UK. Prior to moving to Western in 2016, he was a National Institute for Health Research Clinical Trials Fellow at the Oxford Clinical Trials Research Unit and Consultant Gastroenterologist at Oxford University hospitals.

He is a practising gastroenterologist and specialist in inflammatory bowel disease, and his research interests in clinical therapeutics for IBD include design of clinical trials, development and validation of outcome measures for use in clinical trials, patient reported outcome measures and prediction modelling for response to therapy.

Achievements

Vipul has driven the development and validation of several novel indices for use in IBD clinical trials, like the UC-100 and the novel patient reported outcome measures, SIQ-UC and SIQ-CD. In addition, he was instrumental to the delivery of the REACT2 trial and to the design of the VERDICT trial, both of which are important clinical practice questions for patients with Crohn’s Disease and Ulcerative Colitis, respectively.

Ethos

“We are what we repeatedly do. Excellence, then, is not an act, but a habit.” — Aristotle


Dot

Board of Directors

Ross Feldman

MD, FACP, FAHA, FRCPC

Ross Feldman

MD, FACP, FAHA, FRCPC

Dr. Ross Feldman is Medical Director, Cardiac Sciences Program for the Winnipeg Regional Health Authority, in addition he is also Professor of Medicine at the University of Manitoba.

He was just recently the Chair of Medicine at Memorial University of Newfoundland, St. John’s Newfoundland & Labrador, Canada. He is the author of more than 200 original manuscripts, reviews and book chapters. His clinical research program centers on the development of new approaches to the management of hypertension and specifically the development of innovative strategies to improve blood pressure control.

A major focus of his efforts has been in the prevention and control of hypertension in Canada and specifically in the knowledge translation of optimal treatment approaches for hypertension management. Among past leadership positions, Dr. Feldman served as the first Chair of the Steering Committee of the Canadian Hypertension Education Program, the organization that since 1999 has produced, disseminated and implemented annually updated guidelines for management of hypertension. As well, he served as President of the Canadian Hypertension Society. He was also the founding President of Hypertension Canada- leading the process of integrating the efforts of the Canadian Hypertension Society, Canadian Hypertension Education Program and Blood Pressure Canada.

He has received a number of awards and scholarships in recognition of his contributions in research, teaching and for his efforts in the prevention and control of hypertension in Canada. These include the George Morris Piersol Research and Teaching Scholarship from the American College of Physicians, a Career Investigator Award from the Heart and Stroke Foundation of Ontario, the Burroughs-Wellcome Clinical Pharmacology Award and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology as well as the Distinguished Service/Research Award of the Canadian Hypertension Society. He also the recipient of the George Fodor Award from Hypertension Canada for outstanding contributions to the prevention and control of hypertension.


Paul Knill

LLB, ICD.D

Paul Knill

LLB, ICD.D

Paul Knill earned his law degree from Western University, and is a graduate of the Institute of Corporate Directors, Rotman School of Management.

Paul served as Managing Partner at the Canadian Law Firm, Siskinds LLP, during a period of significant expansion and change. His leadership encouraged innovative gathering and sharing of intellectual capital among business unit members. Paul went on to serve as an adjunct professor at Western University law school, and he currently contributes his corporate governance expertise by serving on the boards of a diverse number of Corporations.


F. John Mills

MD, PhD

F. John Mills

MD, PhD

Dr. Mills co-founded BioStorage Technologies Inc. (BST) in 2002, recognizing the need for the biopharmaceutical industry to store and manage samples for future biomarker and target identification as well as for analyses performed to meet regulatory requirements. He grew BST through angel and series A funding to a global company that was acquired by Brooks Automation in December 2015.

Since that time, he has been Chairman of DGP Intelsius Ltd., a UK headquartered company specializing in global cold chain packaging solutions. He also serves on the boards of hc1.com, a pioneer in healthcare relationship management and Diversigen Inc., an early stage Company at Baylor College of Medicine. He has also been a director of IBT Labs and Chantest, both of which were acquired in successful transactions. Before founding BST, Dr. Mills served for four years as corporate senior vice president and president of clinical support services for Covance, Inc., a leading contract research organization headquartered in Princeton, New Jersey. While there, he was responsible for a clinical services division that employed more than 2,000 staff globally. From 1991 to 1998 he was corporate vice president and president of Covance’s clinical business in Europe, operating in 14 countries.

Prior to 1991, Dr. Mills held senior positions for Johnson and Johnson’s pharmaceutical division in Asia (based in Singapore) and the U.K. From 1976 to 1982 he served in the Royal Air Force as a specialist in Aviation Medicine at Farnborough, UK. Dr. Mills received his MD from Cambridge University and his PhD in endocrinology from Surrey University in the United Kingdom. He holds diplomas in pharmaceutical medicine, aviation medicine and marketing and has authored more than 40 scientific papers as well as a textbook on aviation medicine.



Ross Feldman

MD, FACP, FAHA, FRCPC

Dr. Ross Feldman is Medical Director, Cardiac Sciences Program for the Winnipeg Regional Health Authority, in addition he is also Professor of Medicine at the University of Manitoba.

He was just recently the Chair of Medicine at Memorial University of Newfoundland, St. John’s Newfoundland & Labrador, Canada. He is the author of more than 200 original manuscripts, reviews and book chapters. His clinical research program centers on the development of new approaches to the management of hypertension and specifically the development of innovative strategies to improve blood pressure control.

A major focus of his efforts has been in the prevention and control of hypertension in Canada and specifically in the knowledge translation of optimal treatment approaches for hypertension management. Among past leadership positions, Dr. Feldman served as the first Chair of the Steering Committee of the Canadian Hypertension Education Program, the organization that since 1999 has produced, disseminated and implemented annually updated guidelines for management of hypertension. As well, he served as President of the Canadian Hypertension Society. He was also the founding President of Hypertension Canada- leading the process of integrating the efforts of the Canadian Hypertension Society, Canadian Hypertension Education Program and Blood Pressure Canada.

He has received a number of awards and scholarships in recognition of his contributions in research, teaching and for his efforts in the prevention and control of hypertension in Canada. These include the George Morris Piersol Research and Teaching Scholarship from the American College of Physicians, a Career Investigator Award from the Heart and Stroke Foundation of Ontario, the Burroughs-Wellcome Clinical Pharmacology Award and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology as well as the Distinguished Service/Research Award of the Canadian Hypertension Society. He also the recipient of the George Fodor Award from Hypertension Canada for outstanding contributions to the prevention and control of hypertension.



Paul Knill

LLB, ICD.D

Paul Knill earned his law degree from Western University, and is a graduate of the Institute of Corporate Directors, Rotman School of Management.

Paul served as Managing Partner at the Canadian Law Firm, Siskinds LLP, during a period of significant expansion and change. His leadership encouraged innovative gathering and sharing of intellectual capital among business unit members. Paul went on to serve as an adjunct professor at Western University law school, and he currently contributes his corporate governance expertise by serving on the boards of a diverse number of Corporations.



F. John Mills

MD, PhD

Dr. Mills co-founded BioStorage Technologies Inc. (BST) in 2002, recognizing the need for the biopharmaceutical industry to store and manage samples for future biomarker and target identification as well as for analyses performed to meet regulatory requirements. He grew BST through angel and series A funding to a global company that was acquired by Brooks Automation in December 2015.

Since that time, he has been Chairman of DGP Intelsius Ltd., a UK headquartered company specializing in global cold chain packaging solutions. He also serves on the boards of hc1.com, a pioneer in healthcare relationship management and Diversigen Inc., an early stage Company at Baylor College of Medicine. He has also been a director of IBT Labs and Chantest, both of which were acquired in successful transactions. Before founding BST, Dr. Mills served for four years as corporate senior vice president and president of clinical support services for Covance, Inc., a leading contract research organization headquartered in Princeton, New Jersey. While there, he was responsible for a clinical services division that employed more than 2,000 staff globally. From 1991 to 1998 he was corporate vice president and president of Covance’s clinical business in Europe, operating in 14 countries.

Prior to 1991, Dr. Mills held senior positions for Johnson and Johnson’s pharmaceutical division in Asia (based in Singapore) and the U.K. From 1976 to 1982 he served in the Royal Air Force as a specialist in Aviation Medicine at Farnborough, UK. Dr. Mills received his MD from Cambridge University and his PhD in endocrinology from Surrey University in the United Kingdom. He holds diplomas in pharmaceutical medicine, aviation medicine and marketing and has authored more than 40 scientific papers as well as a textbook on aviation medicine.


Jennifer Roedding

MAcc, CA

Jennifer Roedding

MAcc, CA

Jennifer is an accomplished and innovative business transformation consultant and executive leader with over 20 years of experience adding value and delivering exceptional results to clients.

Jennifer’s experience spans a wide range of clients: from start ups to publicly traded companies. She has worked across many industries including health and life sciences, technology and telecommunications, finance/private equity, public sector, loyalty/call centres and energy. She has assisted organizations with transforming their business processes, change management, governance and organizational realignment, costing and cost modeling, cost optimization and efficiency, as well as mergers/acquisitions/integrations/separations. She has international experience with clients and service delivery teams.

Jennifer graduated from the University of Waterloo with a Master of Accounting degree with a management specialization. Her Master’s thesis was in the area of health case costing and was governmentally funded. Jennifer is certified in Lean Fundamentals through Cardiff University. She is a CA/CPA. Jennifer is currently President of Roedding Associates Management Consultants. Prior to that, she was a Partner in KPMG’s Management Consulting practice.


Jürgen Schölmerich

MD

Jürgen Schölmerich

MD

Prof. Schölmerich studied in Freiburg and Heidelberg. His further qualification in Internal Medicine and Gastroenterology was obtained in Freiburg. He was also a research fellow at the University of California at San Diego.

From 1991 until 2010 he was Director of the Department for Internal Medicine I at the University of Regensburg. He was vice president of the German Research Foundation (DFG) from 2005 until 2011 and president of the “German Association of Internal Medicine” (DGIM) 2009-2010. From 2010 until 2016 he was Medical Director and CEO of the Hospital of Johann Wolfgang Goethe University Frankfurt.

His research interests were: inflammatory bowel disease, complications of Liver cirrhosis and bile acid metabolism and effects.

He has published 93 monographs and chapters in teaching and reference books, he is editor or coeditor of 50 books, and his citations exceed 18,000.


Cecil Shewchuk

BEndSc, PhD

Cecil Shewchuk

BEndSc, PhD

Dr. Cecil Shewchuk, Principal of Shewchuk Consulting, provides consulting services to technology companies in the areas of business planning, technology and product development, sales and marketing strategy, and implementation roll-out. Many of these consulting engagements have been for international companies specializing in the energy sector.

Dr. Shewchuk has held various executive level positions with large technology companies like Aspen Technology and Honeywell where he was responsible for the strategic planning of sophisticated software products and services in such areas as process simulation, optimization, data analytics and advanced process control.

Dr. Shewchuk has been involved with numerous start-up technology companies in the roles of director, founder, manager or mentor. Many of these companies have been successful in growing into viable profitable operations.

Born in Saskatoon, Saskatchewan, he graduated from the University of Saskatchewan with a Bachelor of Engineering Science degree in Chemical Engineering. He earned his doctorate in Chemical Engineering from Cambridge University in England.



Jennifer Roedding

MAcc, CA

Jennifer is an accomplished and innovative business transformation consultant and executive leader with over 20 years of experience adding value and delivering exceptional results to clients.

Jennifer’s experience spans a wide range of clients: from start ups to publicly traded companies. She has worked across many industries including health and life sciences, technology and telecommunications, finance/private equity, public sector, loyalty/call centres and energy. She has assisted organizations with transforming their business processes, change management, governance and organizational realignment, costing and cost modeling, cost optimization and efficiency, as well as mergers/acquisitions/integrations/separations. She has international experience with clients and service delivery teams.

Jennifer graduated from the University of Waterloo with a Master of Accounting degree with a management specialization. Her Master’s thesis was in the area of health case costing and was governmentally funded. Jennifer is certified in Lean Fundamentals through Cardiff University. She is a CA/CPA. Jennifer is currently President of Roedding Associates Management Consultants. Prior to that, she was a Partner in KPMG’s Management Consulting practice.



Jürgen Schölmerich

MD

Prof. Schölmerich studied in Freiburg and Heidelberg. His further qualification in Internal Medicine and Gastroenterology was obtained in Freiburg. He was also a research fellow at the University of California at San Diego.

From 1991 until 2010 he was Director of the Department for Internal Medicine I at the University of Regensburg. He was vice president of the German Research Foundation (DFG) from 2005 until 2011 and president of the “German Association of Internal Medicine” (DGIM) 2009-2010. From 2010 until 2016 he was Medical Director and CEO of the Hospital of Johann Wolfgang Goethe University Frankfurt.

His research interests were: inflammatory bowel disease, complications of Liver cirrhosis and bile acid metabolism and effects.

He has published 93 monographs and chapters in teaching and reference books, he is editor or coeditor of 50 books, and his citations exceed 18,000.



Cecil Shewchuk

BEndSc, PhD

Dr. Cecil Shewchuk, Principal of Shewchuk Consulting, provides consulting services to technology companies in the areas of business planning, technology and product development, sales and marketing strategy, and implementation roll-out. Many of these consulting engagements have been for international companies specializing in the energy sector.

Dr. Shewchuk has held various executive level positions with large technology companies like Aspen Technology and Honeywell where he was responsible for the strategic planning of sophisticated software products and services in such areas as process simulation, optimization, data analytics and advanced process control.

Dr. Shewchuk has been involved with numerous start-up technology companies in the roles of director, founder, manager or mentor. Many of these companies have been successful in growing into viable profitable operations.

Born in Saskatoon, Saskatchewan, he graduated from the University of Saskatchewan with a Bachelor of Engineering Science degree in Chemical Engineering. He earned his doctorate in Chemical Engineering from Cambridge University in England.


Jeff Smith

Chief Executive Officer

Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.

Background

Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).

Achievements

Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.

Ethos

“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”


Stephan R. Targan

MD

Stephan R. Targan

MD

Stephan R. Targan MD is the Director of the Cedars-Sinai Inflammatory Bowel and Immunobiology Research Institute.

As a practicing gastroenterologist and professor of medicine for more than 40 years, Dr. Targan has specialized in treating the most complicated cases of inflammatory bowel disease (IBD) and has trained hundreds of medical students, interns, residents and fellows and an equal number of pre- and post-doctoral researchers and scientists.

In 1990 and even before, Dr. Targan became a vocal advocate and contributor to the body of knowledge regarding heterogeneity among the inflammatory bowel diseases, and the need to define phenotypic subgroups based on combinations of clinical, genetic and biomarker data. In this way, targets will be discovered, and treatments developed with high likelihood of efficacy in defined populations. As a basic and translational scientist, Dr. Targan has made numerous discoveries resulting in improved diagnostics and treatments for Crohn’s disease and ulcerative colitis. Notably, original findings from his laboratory led to the first biologic drugs for IBD.

In 1996, Dr. Targan co-founded Prometheus Laboratories, Inc., and also served as chief scientific officer and member of the board of directors. In 2001, Dr. Targan co-founded Santarus, Inc. and served on the board of directors. Dr. Targan is currently a founding partner and Chief Medical Officer of Precision IBD, Inc.



Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.

Background

Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).

Achievements

Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.

Ethos

“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”



Stephan R. Targan

MD

Stephan R. Targan MD is the Director of the Cedars-Sinai Inflammatory Bowel and Immunobiology Research Institute.

As a practicing gastroenterologist and professor of medicine for more than 40 years, Dr. Targan has specialized in treating the most complicated cases of inflammatory bowel disease (IBD) and has trained hundreds of medical students, interns, residents and fellows and an equal number of pre- and post-doctoral researchers and scientists.

In 1990 and even before, Dr. Targan became a vocal advocate and contributor to the body of knowledge regarding heterogeneity among the inflammatory bowel diseases, and the need to define phenotypic subgroups based on combinations of clinical, genetic and biomarker data. In this way, targets will be discovered, and treatments developed with high likelihood of efficacy in defined populations. As a basic and translational scientist, Dr. Targan has made numerous discoveries resulting in improved diagnostics and treatments for Crohn’s disease and ulcerative colitis. Notably, original findings from his laboratory led to the first biologic drugs for IBD.

In 1996, Dr. Targan co-founded Prometheus Laboratories, Inc., and also served as chief scientific officer and member of the board of directors. In 2001, Dr. Targan co-founded Santarus, Inc. and served on the board of directors. Dr. Targan is currently a founding partner and Chief Medical Officer of Precision IBD, Inc.


Dot

Operations Management

Tom Currie

Director, Finance

Tom Currie

Director, Finance

Tom Currie • Director, Finance

Tom has been the Director of Finance at Alimentiv since 2012. His success in providing financial leadership for the organization contributes consistently to Alimentiv’s strategic direction.

Background

Prior to this role, Tom held senior financial positions at PharmaNet/i3 as it transitioned through three different ownership structures. He previously gained significant public accounting experience. He holds a CPA accounting designation and has an honours degree in business.

Achievements

Tom was instrumental in creating Alimentiv’s initial corporate structure and established its finance department and initial finance systems. He contributed to the restructuring of the organization in 2018 and continues to support structure and financing initiatives.

Ethos

“A steady hand at the wheel makes for a more productive and enjoyable journey in life, work and relationships.”


Judi Hall

Director, Data Sciences

Judi Hall

Director, Data Sciences

Judi provides leadership and oversight to the global activities and timelines related to data management and statistical services.

Background

Judi has worked for over 20 years in clinical trial project management, data management and statistical services, with experience across many therapeutic areas at pharmaceutical, CRO and academic organizations.

Achievements

Judi understands the data landscape, and partners with clients and stakeholders to deliver meaningful insights and data integrity. She’s passionate about using data to drive decisions and create efficiencies.

Ethos

“High-quality data is at the core of evidence-based decision-making.”


Jeremy Langohr

Director, Information Technology

Jeremy Langohr

Director, Information Technology

Since 2012, Jeremy has been responsible for leading and overseeing IT infrastructure and software development teams, operations and strategy.

Background

Jeremy is a graduate of the University of Western Ontario and began his career in IT in 2002. He has held several positions in not-for-profit, public and private life sciences environments, supporting thousands of users around the world. His credentials include Certified Information Systems Security Professional (CISSP), Certified in Risk and Information Systems Control (CRISC) and IT Service Management (ITIL) certifications.

Achievements

Jeremy has successfully led several large digital transformation and complex infrastructure migrations including the 2016 Robarts Clinical Trials head office and datacenter relocation, cloud adoption projects and multiple security initiatives.

Ethos

“People and process are fundamental to the success of any technology.”



Tom Currie

Director, Finance

Tom Currie • Director, Finance

Tom has been the Director of Finance at Alimentiv since 2012. His success in providing financial leadership for the organization contributes consistently to Alimentiv’s strategic direction.

Background

Prior to this role, Tom held senior financial positions at PharmaNet/i3 as it transitioned through three different ownership structures. He previously gained significant public accounting experience. He holds a CPA accounting designation and has an honours degree in business.

Achievements

Tom was instrumental in creating Alimentiv’s initial corporate structure and established its finance department and initial finance systems. He contributed to the restructuring of the organization in 2018 and continues to support structure and financing initiatives.

Ethos

“A steady hand at the wheel makes for a more productive and enjoyable journey in life, work and relationships.”



Judi Hall

Director, Data Sciences

Judi provides leadership and oversight to the global activities and timelines related to data management and statistical services.

Background

Judi has worked for over 20 years in clinical trial project management, data management and statistical services, with experience across many therapeutic areas at pharmaceutical, CRO and academic organizations.

Achievements

Judi understands the data landscape, and partners with clients and stakeholders to deliver meaningful insights and data integrity. She’s passionate about using data to drive decisions and create efficiencies.

Ethos

“High-quality data is at the core of evidence-based decision-making.”



Jeremy Langohr

Director, Information Technology

Since 2012, Jeremy has been responsible for leading and overseeing IT infrastructure and software development teams, operations and strategy.

Background

Jeremy is a graduate of the University of Western Ontario and began his career in IT in 2002. He has held several positions in not-for-profit, public and private life sciences environments, supporting thousands of users around the world. His credentials include Certified Information Systems Security Professional (CISSP), Certified in Risk and Information Systems Control (CRISC) and IT Service Management (ITIL) certifications.

Achievements

Jeremy has successfully led several large digital transformation and complex infrastructure migrations including the 2016 Robarts Clinical Trials head office and datacenter relocation, cloud adoption projects and multiple security initiatives.

Ethos

“People and process are fundamental to the success of any technology.”


Christine Müeller Rosenau

Director, Clinical Study Management

Christine Müeller Rosenau

Director, Clinical Study Management

Managing Alimentiv’s highly experienced and dedicated global Full Service Project Management group, Christine’s focus is on ensuring successful project delivery, understanding client needs and helping her team members further develop and grow.

Background

Christine’s career in clinical studies started in 1995 as a CRA with a global CRO. She managed 20+ global studies in a variety of indications as a Project Manager and Project Director prior to moving into her current role in 2016.

Christine has a Masters degree in Biology and English, and is a PMP certified Project Manager.

Achievements

Christine helped to implement Alimentiv’s footprint in Europe by managing the organization’s first global UC study. She also implemented the Startup Specialist Role at Alimentiv and coordinated the streamlining of the organization’s site startup processes.

Ethos

“I think that as a manager you need to ‘walk the talk.’ I strongly believe in integrity and in Alimentiv’s values. They are the basis of my day-to-day work and interactions with clients and my team.”


Michael Nicell

Director, Business Development

Michael Nicell

Director, Business Development

Mike has led the business development and marketing teams at Alimentiv since 2015. His focus is finding solutions to clients’ ever-changing needs in the field of gastrointestinal research.

Background

Mike has spent his 30+ year career on the commercial side of the medical device and pharmaceutical industry. He has worked for companies in both areas and has a strong understanding of all aspects of the clinical research process. He listens to clients, understands the clinical trial at hand, and develops/presents accurate, clear and transparent plans.

Mike has a Bachelor of Science and an Honors Bachelor of Commerce.

Achievements

Mike counts as his achievements the growth of good organizations like Alimentiv that employ talented people and work together to drive drug development ahead.

Ethos

“Winning in business is not about satisfaction of one’s own needs and wants or getting the upper hand in a negotiation, but truly about working with great people, delivering high-quality work that meets our sponsors’ needs.”


Daniel Philpott

Director, Clinical Operations

Daniel Philpott

Director, Clinical Operations

Daniel is responsible for the oversight and strategic direction of Alimentiv’s Monitoring and Site Management group, Trial Master File Operations group and Logisitics Group. He embraces continuous improvement and innovation to drive the development of more efficient and effective processes, technology and organizational design.

Background

Daniel has over 20 years of progressive experience in clinical research, at both CROs and Pharma companies. Prior to joining Alimentiv in 2017, Daniel was Senior Manager and Process Lead within the Pfizer SBU at PAREXEL. He is a certified Clinical Research Professional, holds an honours Degree in Biochemistry as well as an MBA specialized in the Management of Technology and Innovation.

Achievements

With a commitment to driving innovation, Daniel has been integral to the deployment of new processes and technology platforms facilitating internal efficiencies and external service offerings.

Ethos

“Providing the environment and opportunity for this growth is a core responsibility. I love watching and encouraging the growth and development of people and ideas within the organization.”



Christine Müeller Rosenau

Director, Clinical Study Management

Managing Alimentiv’s highly experienced and dedicated global Full Service Project Management group, Christine’s focus is on ensuring successful project delivery, understanding client needs and helping her team members further develop and grow.

Background

Christine’s career in clinical studies started in 1995 as a CRA with a global CRO. She managed 20+ global studies in a variety of indications as a Project Manager and Project Director prior to moving into her current role in 2016.

Christine has a Masters degree in Biology and English, and is a PMP certified Project Manager.

Achievements

Christine helped to implement Alimentiv’s footprint in Europe by managing the organization’s first global UC study. She also implemented the Startup Specialist Role at Alimentiv and coordinated the streamlining of the organization’s site startup processes.

Ethos

“I think that as a manager you need to ‘walk the talk.’ I strongly believe in integrity and in Alimentiv’s values. They are the basis of my day-to-day work and interactions with clients and my team.”



Michael Nicell

Director, Business Development

Mike has led the business development and marketing teams at Alimentiv since 2015. His focus is finding solutions to clients’ ever-changing needs in the field of gastrointestinal research.

Background

Mike has spent his 30+ year career on the commercial side of the medical device and pharmaceutical industry. He has worked for companies in both areas and has a strong understanding of all aspects of the clinical research process. He listens to clients, understands the clinical trial at hand, and develops/presents accurate, clear and transparent plans.

Mike has a Bachelor of Science and an Honors Bachelor of Commerce.

Achievements

Mike counts as his achievements the growth of good organizations like Alimentiv that employ talented people and work together to drive drug development ahead.

Ethos

“Winning in business is not about satisfaction of one’s own needs and wants or getting the upper hand in a negotiation, but truly about working with great people, delivering high-quality work that meets our sponsors’ needs.”



Daniel Philpott

Director, Clinical Operations

Daniel is responsible for the oversight and strategic direction of Alimentiv’s Monitoring and Site Management group, Trial Master File Operations group and Logisitics Group. He embraces continuous improvement and innovation to drive the development of more efficient and effective processes, technology and organizational design.

Background

Daniel has over 20 years of progressive experience in clinical research, at both CROs and Pharma companies. Prior to joining Alimentiv in 2017, Daniel was Senior Manager and Process Lead within the Pfizer SBU at PAREXEL. He is a certified Clinical Research Professional, holds an honours Degree in Biochemistry as well as an MBA specialized in the Management of Technology and Innovation.

Achievements

With a commitment to driving innovation, Daniel has been integral to the deployment of new processes and technology platforms facilitating internal efficiencies and external service offerings.

Ethos

“Providing the environment and opportunity for this growth is a core responsibility. I love watching and encouraging the growth and development of people and ideas within the organization.”


Gabriela Radulescu

Director, Medical Operations

Gabriela Radulescu

Director, Medical Operations

Gabriela provides medical leadership for sponsor clinical trials, operational oversight for research and development projects, and medical input to the business development teams.

Background

Gabriela obtained her medical degree at the University of Medicine and Pharmacy Iuliu Hatieganu in Cluj – Napoca, Romania. Since then, she has acquired more than 20 years of experience working in the pharmaceutical industry in Canada in various leadership roles and across multiple functions including medical affairs, drug safety and pharmacovigilance, clinical research and real world evidence, and patient support programs. Prior to joining Alimentiv, Gabriela led a team of scientific professionals as a Medical Affairs Director in IBD.

Achievements

Since joining Alimentiv, through her multidisciplinary experience, Gabriela has been able to bring significant contributions to the development and implementation of organizational strategies and best practices. Her focus on the medical research and development area ensures a continued adherence to delivering high-quality research and science, superior customer service and people development.

Ethos

“I approach my role with the conviction that what we do matters for patients and physicians, and through our work we advance our mission to support human health. I believe it is important that every member of the Alimentiv team is authentic and brings their full contribution to the success of the organization.”


Courtney Sweet

Director, Imaging Project Operations

Courtney Sweet

Director, Imaging Project Operations

Courtney Sweet is the Director, Imaging Project Operations at Alimentiv Clinical Trials and is responsible for providing leadership and oversight of the global activities and timelines related to imaging projects.

Courtney has 18 years of experience in the clinical research field spanning over a number of clinical operations positions in pharmaceutical and CRO companies. Courtney started her career in 1999 as a Clinical Trial Associate for a biotechnology company. She then spent 5 years as a CRA at Pfizer, monitoring Phase I – III studies across multiple therapeutic areas in North America.

Prior to joining Alimentiv, Courtney was a Clinical Study Manager and Associate Director of project management at Quintiles, overseeing project delivery for large global trials in oncology and rheumatoid arthritis. Courtney joined Alimentiv in 2013 as a Project Director. Over the past 4 years she has lead full service trials as well as imaging studies involving endoscopy, histopathology and MRE. Courtney holds a Bachelor’s Degree in Biology and Psychology.


Karen Toulouse

Director, Quality Assurance

Karen Toulouse

Director, Quality Assurance

Responsible for Quality Assurance at Alimentiv since 2005, Karen has built the  QA department into an eight-member team that hosts agency inspections, conducts internal audits, assesses vendors and oversees QA for the organization.

Background

Karen spent 10 years at Eli Lilly in a variety of roles including Data Management, Clinical Monitor, Clinical Project Manager and Training Leader. She has been a member of the SQA since 2006 and was RQAP-GCP certified in 2009.

Achievements

Successfully hosted the FDA in 2017 with no 483 or verbal observations.

Ethos

“Kindness, patience and empathy are the most powerful tools in my tool chest.”



Gabriela Radulescu

Director, Medical Operations

Gabriela provides medical leadership for sponsor clinical trials, operational oversight for research and development projects, and medical input to the business development teams.

Background

Gabriela obtained her medical degree at the University of Medicine and Pharmacy Iuliu Hatieganu in Cluj – Napoca, Romania. Since then, she has acquired more than 20 years of experience working in the pharmaceutical industry in Canada in various leadership roles and across multiple functions including medical affairs, drug safety and pharmacovigilance, clinical research and real world evidence, and patient support programs. Prior to joining Alimentiv, Gabriela led a team of scientific professionals as a Medical Affairs Director in IBD.

Achievements

Since joining Alimentiv, through her multidisciplinary experience, Gabriela has been able to bring significant contributions to the development and implementation of organizational strategies and best practices. Her focus on the medical research and development area ensures a continued adherence to delivering high-quality research and science, superior customer service and people development.

Ethos

“I approach my role with the conviction that what we do matters for patients and physicians, and through our work we advance our mission to support human health. I believe it is important that every member of the Alimentiv team is authentic and brings their full contribution to the success of the organization.”



Courtney Sweet

Director, Imaging Project Operations

Courtney Sweet is the Director, Imaging Project Operations at Alimentiv Clinical Trials and is responsible for providing leadership and oversight of the global activities and timelines related to imaging projects.

Courtney has 18 years of experience in the clinical research field spanning over a number of clinical operations positions in pharmaceutical and CRO companies. Courtney started her career in 1999 as a Clinical Trial Associate for a biotechnology company. She then spent 5 years as a CRA at Pfizer, monitoring Phase I – III studies across multiple therapeutic areas in North America.

Prior to joining Alimentiv, Courtney was a Clinical Study Manager and Associate Director of project management at Quintiles, overseeing project delivery for large global trials in oncology and rheumatoid arthritis. Courtney joined Alimentiv in 2013 as a Project Director. Over the past 4 years she has lead full service trials as well as imaging studies involving endoscopy, histopathology and MRE. Courtney holds a Bachelor’s Degree in Biology and Psychology.



Karen Toulouse

Director, Quality Assurance

Responsible for Quality Assurance at Alimentiv since 2005, Karen has built the  QA department into an eight-member team that hosts agency inspections, conducts internal audits, assesses vendors and oversees QA for the organization.

Background

Karen spent 10 years at Eli Lilly in a variety of roles including Data Management, Clinical Monitor, Clinical Project Manager and Training Leader. She has been a member of the SQA since 2006 and was RQAP-GCP certified in 2009.

Achievements

Successfully hosted the FDA in 2017 with no 483 or verbal observations.

Ethos

“Kindness, patience and empathy are the most powerful tools in my tool chest.”


Niels Vande Casteele

PharmD, PhD Director, Precision Medicine

Niels Vande Casteele

PharmD, PhD Director, Precision Medicine

Dr. Vande Casteele established the the precision medicine group where he oversees the development, validation and operationalization of clinical pharmacology & translational medicine research tools to ascertain efficient drug development.

Background

Dr. Vande Casteele holds a Bachelor in Pharmaceutical Sciences and Masters in Drug Design and Development from the University of Leuven, Belgium. He performed research in the field of Molecular Biology at the Institute of Medical Sciences, University of Aberdeen, Scotland, and in the field of Immunology at Sanquin, University of Amsterdam, the Netherlands. He obtained his Ph.D. in Pharmaceutical Sciences entitled “Optimizing anti-TNF therapy in inflammatory bowel disease patients, a step towards personalized dosing” at the University of Leuven, Belgium.

Dr. Vande Casteele currently holds an appointment as Assistant Professor of Medicine at the University of California San Diego, United States, where he teaches a course on Biologics and Biosimilars Drug Development. His main research efforts focus on clinical pharmacology and translational medicine of small and large molecules used in the treatment of chronic inflammatory diseases, with an emphasis on characterizing pharmacokinetics and pharmacodynamics in relation to treatment outcomes in clinical practice and drug development.

Achievements

Dr. Vande Casteele has published over 100 peer reviewed research articles and book chapters; has given over 30 invited lectures; and has received awards for his research contributions from distinguished professional organizations such as the European Crohn’s and Colitis Organization (ECCO), the American Gastroenterological Association (AGA), the Crohn’s and Colitis Foundation (CCF) and United European Gastroenterology (UEG) association.

Ethos

“Just like you have to climb the mountain in order to see the view, doing scientific research requires inquisitiveness, adaptiveness and a team approach to overcome hurdles in order to reach the objective.”



Niels Vande Casteele

PharmD, PhD Director, Precision Medicine

Dr. Vande Casteele established the the precision medicine group where he oversees the development, validation and operationalization of clinical pharmacology & translational medicine research tools to ascertain efficient drug development.

Background

Dr. Vande Casteele holds a Bachelor in Pharmaceutical Sciences and Masters in Drug Design and Development from the University of Leuven, Belgium. He performed research in the field of Molecular Biology at the Institute of Medical Sciences, University of Aberdeen, Scotland, and in the field of Immunology at Sanquin, University of Amsterdam, the Netherlands. He obtained his Ph.D. in Pharmaceutical Sciences entitled “Optimizing anti-TNF therapy in inflammatory bowel disease patients, a step towards personalized dosing” at the University of Leuven, Belgium.

Dr. Vande Casteele currently holds an appointment as Assistant Professor of Medicine at the University of California San Diego, United States, where he teaches a course on Biologics and Biosimilars Drug Development. His main research efforts focus on clinical pharmacology and translational medicine of small and large molecules used in the treatment of chronic inflammatory diseases, with an emphasis on characterizing pharmacokinetics and pharmacodynamics in relation to treatment outcomes in clinical practice and drug development.

Achievements

Dr. Vande Casteele has published over 100 peer reviewed research articles and book chapters; has given over 30 invited lectures; and has received awards for his research contributions from distinguished professional organizations such as the European Crohn’s and Colitis Organization (ECCO), the American Gastroenterological Association (AGA), the Crohn’s and Colitis Foundation (CCF) and United European Gastroenterology (UEG) association.

Ethos

“Just like you have to climb the mountain in order to see the view, doing scientific research requires inquisitiveness, adaptiveness and a team approach to overcome hurdles in order to reach the objective.”